These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 25144777)

  • 21. [Hepatobiliary manifestations in inflammatory bowel disease].
    Solís Herruzo JA; Solís-Muñoz P
    Rev Esp Enferm Dig; 2007 Sep; 99(9):525-42. PubMed ID: 18052648
    [No Abstract]   [Full Text] [Related]  

  • 22. Hepatobiliary disease in inflammatory bowel disease.
    Ahmad J; Slivka A
    Gastroenterol Clin North Am; 2002 Mar; 31(1):329-45. PubMed ID: 12122741
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hepatobiliary disease in cystic fibrosis].
    Pérez-Aguilar F; Berenguer Lapuerta J
    Med Clin (Barc); 1998 Sep; 111(8):302-6. PubMed ID: 9810550
    [No Abstract]   [Full Text] [Related]  

  • 24. Impact of inflammatory bowel disease and ursodeoxycholic acid therapy on small-duct primary sclerosing cholangitis.
    Charatcharoenwitthaya P; Angulo P; Enders FB; Lindor KD
    Hepatology; 2008 Jan; 47(1):133-42. PubMed ID: 17992695
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Review article: current management of primary sclerosing cholangitis.
    Cullen SN; Chapman RW
    Aliment Pharmacol Ther; 2005 Apr; 21(8):933-48. PubMed ID: 15813829
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Liver and inflammatory bowel disease.
    Nahon S; Cadranel JF; Chazouilleres O; Biour M; Jouannaud V; Marteau P
    Gastroenterol Clin Biol; 2009 May; 33(5):370-81. PubMed ID: 19394180
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The benign course of liver disease in adults with cystic fibrosis and the effect of ursodeoxycholic acid.
    Desmond CP; Wilson J; Bailey M; Clark D; Roberts SK
    Liver Int; 2007 Dec; 27(10):1402-8. PubMed ID: 18036103
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sclerosing Cholangitis in Children and Adolescents.
    Mieli-Vergani G; Vergani D
    Clin Liver Dis; 2016 Feb; 20(1):99-111. PubMed ID: 26593293
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary sclerosing cholangitis.
    Zein CO; Lindor KD
    Semin Gastrointest Dis; 2001 Apr; 12(2):103-12. PubMed ID: 11352117
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Autoimmune liver disease: diagnosis and therapy].
    Bayer EM; Schramm C; Kanzler S; Lohse AW
    Z Gastroenterol; 2004 Jan; 42(1):19-30. PubMed ID: 14997400
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primary sclerosing cholangitis in pregnancy refractory to ursodeoxycholic acid treatment: a case report.
    Leftwich H; Fang YM; Borgida A; Crombleholme W
    J Reprod Med; 2010; 55(11-12):517-9. PubMed ID: 21291041
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment options for primary sclerosing cholangitis.
    Sinakos E; Lindor K
    Expert Rev Gastroenterol Hepatol; 2010 Aug; 4(4):473-88. PubMed ID: 20678020
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ursodeoxycholic acid in the treatment of primary sclerosing cholangitis.
    Stiehl A
    Ital J Gastroenterol; 1996 Apr; 28(3):178-80. PubMed ID: 8789831
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cholestatic liver diseases].
    Thimme R; Opitz OG; Blum HE; Kreisel W
    Ther Umsch; 2004 Aug; 61(8):521-7. PubMed ID: 15457969
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Autoimmune cholestasis syndrome. Ursodeoxycholic acid is the drug standard].
    Stiefelhagen P
    MMW Fortschr Med; 2007 May; 149(21):49. PubMed ID: 17668736
    [No Abstract]   [Full Text] [Related]  

  • 36. A retrospective single-center review of primary sclerosing cholangitis in children.
    Miloh T; Arnon R; Shneider B; Suchy F; Kerkar N
    Clin Gastroenterol Hepatol; 2009 Feb; 7(2):239-45. PubMed ID: 19121649
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Guidelines for therapy of autoimmune liver disease.
    Ishibashi H; Komori A; Shimoda S; Gershwin ME
    Semin Liver Dis; 2007 May; 27(2):214-26. PubMed ID: 17520519
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of ursodeoxycholic acid and vitamin E in the prevention of liver injury from methotrexate in pediatric leukemia.
    Bordbar M; Shakibazad N; Fattahi M; Haghpanah S; Honar N
    Turk J Gastroenterol; 2018 Mar; 29(2):203-209. PubMed ID: 29749328
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical manifestation of hepatotoxic effect of cytostatic chemicals].
    Polunina TE; Maev IV
    Eksp Klin Gastroenterol; 2007; (3):52-4. PubMed ID: 17939196
    [No Abstract]   [Full Text] [Related]  

  • 40. Liver involvement in pediatric celiac disease.
    Anania C; De Luca E; De Castro G; Chiesa C; Pacifico L
    World J Gastroenterol; 2015 May; 21(19):5813-22. PubMed ID: 26019445
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.